Supplements · Sweeteners · Metabolic & Cardiometabolic
stevia does not raise blood glucose
In plain terms: Is stevia safe for your blood sugar?
Part of: • Stevia
Yes - this is stevia's most solid benefit. Your body doesn't turn steviol glycosides into glucose, so stevia doesn't raise blood sugar, and swapping it in for sugar modestly lowers the post-meal glucose and insulin bump. A few of the studies are industry-linked, but the finding is uncontested and makes mechanistic sense.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Stevia is blood-sugar-friendly: steviol glycosides aren't absorbed intact or converted to glucose (gut bacteria cleave them to steviol, which is excreted), so stevia doesn't raise blood sugar — and when it replaces sugar it modestly lowers the post-meal glucose and insulin rise. This is well established and mechanistically clear, the clearest of stevia's health claims.
The evidence (11)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Gregersen S et al. 2004 · Metabolism | RCT | supports | moderate | Acute RCT (12 T2D): 1 g stevioside cut postprandial glucose iAUC 18% vs control; no rise. |
| Zare M et al. 2024 · Clin Nutr ESPEN | meta-analysis | supports | moderate | Meta-analysis of RCTs on stevia and glycemic indices: favorable/neutral glycemic profile, no glucose-raising effect. |
| Smeets PA et al 2026 · study_type: RCT | RCT | supports | high | Randomized crossover (n=30): only sucrose (25g) beverage increased serum glucose and insulin; stevia-extract-only and allulose+stevia beverages did not raise glucose/insulin despite equisweet taste. |
| Bundgaard Anker CC et al. 2019 · Nutrients | meta-analysis | supports | moderate | SR/meta of RCTs (T2D biomarkers): no adverse glucose-raising effect; some modest-benefit signal. |
| Almiron-Roig E et al. 2023 · Food Funct | RCT | supports | moderate | Crossover RCT (SWEET): stevia RebA reduced glucose iAUC vs sucrose (p<0.05), lower insulin iAUC. [industry-adjacent EU consortium funding] |
| Nunez Martinez P et al. 2016 · Nutr Hosp | mechanism | supports | low | Pharmacokinetic review: metabolic fate of rebaudioside A/stevioside consistent with a non-glycemic profile. |
| Galicia-Ayala C et al 2026 · study_type: RCT | RCT | mixed | moderate | Randomized crossover (n=20): sucrose beverage gave highest glucose/insulin rise at 30min; a sucrose+stevia (SUC/STE) blend showed a glucose-LOWERING effect vs sucrose at 60min, not a pure-stevia-alone arm. |
| Lifshitz Y et al 2026 · study_type: RCT | RCT | supports | high | Double-blind crossover RCT (n=19): stevia Reb-M (0.225g) beverage produced glucose/insulin/GLP-1 responses over 120min not significantly different from baseline pattern, and not different from sweelin; both far below dextrose (p<0.0001). |
| Angarita Davila L et al. 2017 · Nutrients | RCT | supports | low | Crossover RCT: stevia had lower glucose iAUC than control; no rise in postprandial insulin. |
| Magnuson BA, Carakostas MC, Moore NH, Poulos SP, Renwick AG 2016 · Nutr Rev | mechanism | supports | low | Narrative review of sweetener biological fate. 'The objectives of this review' are to compare 'status, and biological fate (including absorption, distribution, metabolism, and' excretion of five low-calorie sweeteners. No glycemic outcome is reported anywhere in the readable text, and the previously recorded detail (steviol glycosides cleaved by gut bacteria, excreted, not converted to glucose) does not appear in it. Off-scope on the outcome; would at best be a review-role vote even if the full text carries that statement. Industry-adjacent authorship: 'S.P. Poulos is with the Calorie Control Council, Atlanta, Georgia, USA.' |
| Stamataki NS et al. 2020 · Nutrients | RCT | supports | moderate | 12-wk RCT (healthy adults): daily stevia did not adversely affect glycemia; no rise in glucose-homeostasis markers. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.